hacklink al hack forum organik hit bettiltmeritkingcasibommeritkingcasibomholiganbettrendbetcasino siteleribahis yatırım açığıhttps://betandreas-yukle.com/bettilt güncelçocuk pornosuçocuk pornosuçocuk pornosuçocuk pornosumeritking güncel girişdumanbetdumanbet girişdumanbetdumanbetEscort bayan çeşmeEscort çeşmeÇeşme escortparibahiscasibombahis siteleriDeneme Bonusu Veren Siteler 2024instagram takipçi satın alcasibombets10deneme bonusu veren sitelerdeneme bonusu veren sitelercasibomselcuksportsmatbetjustin tvİstanbul Vip transferdeneme bonusu veren sitelerığdır boşanma avukatıjojobet güncel girişjojobetSleeping Tablets UKcasibomcasibommarsbahisextrabet girişextrabetonwin girişonwinjojobetcasibomvirabetonwincasibom

Halal Pharmacore Market Tracker

The most up-to-date halal pharmaceutical news content in the world.

Top News

Malaysia Set to Help Others Build Halal Ecosystem
Duopharma Biotech Sees Promising Collaboration Opportunities in Qatar
China’s Burgeoning Halal Trade: Implications for the Arab World
Halal Horizons: Future of Pharmaceutical Science at Taylor’s University
Halal Horizons: A Global Convergence at the Makkah Halal Forum
State of the Global Islamic Economy Report 23/2024: A $142 Billion Opportunity
Capitalizing on Halal Pharmaceuticals: The Billion-Dollar Path to Ethical Healthcare
Russia’s Sberbank to Launch Islamic Banking
MIHAS 2023 to Capitalize on Global Halal Economy
Medytox to Build BTX Plant in UAE
Duopharma is First in Malaysia to Receive Halal Certification for Oncology Product
Pharmaniaga, and Ronnsi Pharma Partnership to Commercialize Malaysia’s First Halal Blood Anti-coagulant
Innovent and Etana Jointly Announce the Approval of Bevagen® (Bevacizumab Biosimilar)
South Korea’s Pharma Sector Probes Halal Market with Indonesian Partners
World’s First Halal Biosimilar to Be Produced in Malaysia
Daewoong Infion Achieved Halal Certification for their Diabetic Foot Ulcer Drug, Easyef
AJ Pharma Developing the World’s First Halal Vaccines
Saudi ‘World’s Largest’ Centre for Halal Food & Products
Daewoong Infion: Epodion Halal Certified, First Animal Cell Biopharma

All News

Unleashing Potential: The Rise of the Global Halal Market

Experience the exponential growth of the global halal market, projected to reach $7.7 trillion by 2025. This surge is driven by sectors such as Islamic finance, food and beverage, pharmaceuticals, and more. With consumer spending on halal products expected to hit $2.4 trillion in 2024, the halal industry presents a promising economic sector for investment. Join us in this journey as we explore the untapped potential of the halal market

Unlocking the Halal Goldmine: Invest in the Philippine’s Thriving Halal Market

Philippines aims to become a premier halal hub by 2028, tapping into the $7.7 trillion global halal industry. The strategic plan includes increasing halal-certified products and generating PHP230 billion in domestic halal sector investments. This presents a thriving market for investors, with potential for significant domestic growth and job creation.

Halal Horizons: A Global Convergence at the Makkah Halal Forum

The Makkah Halal Forum, organized by the Islamic Chamber Halal Services and Manafea, is a pioneering event aimed at revolutionizing the global Halal Market. The forum will host workshops, panels, and exhibitions to address critical issues in the Halal economy and meet the needs of Muslim consumers. This 3-day event promotes cross-sector collaborations and drives the growth of the Halal market globally.

Philippines to Launch National Halal Strategy

The plan aims to generate $4 billion in trade and investments in all halal sectors including halal food, Islamic finance, halal-friendly travel and tourism, modest fashion, halal pharmaceuticals, and cosmetics.

Malaysia: Building Local Halal Champions

Malaysia to compete globally in the growing halal industry by building a strong halal ecosystem, including infrastructure, regulation, and industry expertise, through collaboration between public and private sectors.

Abdi Ibrahim Purchased OM Pharma’s Shares

he leading Turkish pharmaceutical company Abdi Ibrahim purchased 28.5 per cent of the shares of the Swiss biotech company OM Pharma for TL 4.2 billion (USD 530 million), making it the company’s second-largest shareholder.